SEARCH

SEARCH BY CITATION

References

  • Antonsson B. and Martinou J. C. (2000) The Bcl-2 protein family. Exp. Cell Res. 256, 5057.DOI: 10.1006/excr.2000.4839
  • Ashkenazi A. and Dixit V. M. (1998) Death receptors: signaling and modulation. Science 281, 13051308.DOI: 10.1126/science.281.5381.1305
  • Berger M. R., Sobottka S., Konstantinov S. M. and Eibl H. (1998) Erucylphosphocholine is the prototype of intravenous injectable alkylphosphocholines. Drugs Today 34, 7381.
  • Bratton S. B., MacFarlane M., Cain K. and Cohen G. M. (2000) Protein complexes activate distinct caspase cascades in death receptor and stress-induced apoptosis. Exp. Cell Res. 256, 2733.
  • Cabaner C., Gajate C., Macho A., Munoz E., Modolell M. and Mollinedo F. (1999) Induction of apoptosis in human mitogen-activated peripheral blood T lymphocytes by the ether phospholipid ET-18-OCH3: involvement of the Fas receptor/ligand system. Br. J. Pharmacol. 127, 813825.
  • Cuvillier O., Mayhew E., Janoff A. S. and Spiegel S. (1999) Liposomal ET-18-OCH3 induces cytochrome c-mediated apoptosis independently of CD95 (APO-1/Fas) signaling. Blood 94, 35833592.
  • D'Amours D., Sallmann F. R., Dixit V. M. and Poirier G. G. (2001) Gain-of-function of poly (ADP-ribose) polymerase-1 upon cleavage by apoptotic proteases: implications for apoptosis. J. Cell Sci. 114, 37713778.
  • Dörr J., Bechmann I., Waiczies S., Aktas O., Walczak H., Krammer P.H., Nitsch R. and Zipp F. (2002) Lack of tumor necrosis factor-related apoptosis-inducing ligand but presence of its receptors in the human brain. J. Neurosci. 22, RC209:15.
  • Duan L., Aoyagi M., Tamaki M., Nakagawa K., Nagashima G., Nagasaka Y., Ohno K., Yamamoto K. and Hirakawa K. (2001) Sensitization of human malignant glioma cell lines to tumor necrosis factor-induced apoptosis by cisplatin. J. Neurooncol. 52, 2336.
  • Engels I. H., Stepczynska A., Stroh C., Lauber K., Berg C., Schwenzer R., Wajant H., Jänicke R. U., Porter A. G., Belka C., Gregor M., Schulze-Osthoff K. and Wesselborg S. (2000) Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. Oncogene 19, 45634573.
  • Erdlenbruch B., Jendrossek V., Marx M., Hunold A., Eibl H. and Lakomek M. (1998) Antitumor effects of erucylphosphocholine on brain tumor cells in vitro and in vivo. Anticancer Res. 18, 25512557.
  • Erdlenbruch B., Jendrossek V., Gerriets A., Vetterlein F., Eibl H. and Lakomek M. (1999) Erucylphosphocholine: pharmacokinetics, biodistribution, CNS-accumulation and toxicity in the rat after intravenous application. Cancer Chemother. Pharmacol. 44, 484490.DOI: 10.1007/s002800051122
  • Eue I., Zeisig R. and Arndt D. (1995) Alkylphosphocholine-induced production of nitric oxide and tumor necrosis factor α by U937 cells. J. Cancer Res. Clin. Oncol. 121, 350356.
  • Ferrando-May E., Cordes V., Biller-Ckovric I., Mirkovic J., Görlich D. and Nicotera P. (2001) Caspases mediate nucleoporin cleavage, but not early redistribution of nuclear transport factors and modulation of nuclear permeability in apoptosis. Cell Death Differ. 8, 495505.
  • Ferri K. F. and Kroemer G. (2001) Mitochondria: the suicide organelles. Bioessays 23, 111115.
  • Fulda S., Sieverts H., Friesen C., Herr I. and Debatin K. M. (1997) The CD95 system mediates drug-induced apoptosis in neuroblastoma cells. Cancer Res. 57, 38233829.
  • Fulda S., Meyer E., Friesen C., Susin S. A., Kroemer G. and Debatin K.M. (2001) Cell type specific involvement of death receptor and mitochondrial pathways in drug-induced apoptosis. Oncogene 20, 10631075.
  • García-Calvo M., Peterson E. P., Leiting B., Ruel R., Nicholson D. W. and Thornberry N. A. (1998) Inhibition of human caspases by peptide-based and macromolecular inhibitors. J. Biol. Chem. 273, 3260832613.
  • Green D. R. and Reed J. C. (1998) Mitochondria and apoptosis. Science 281, 13091312.
  • Gu J., Dong R. P., Zhang C., McLaughlin D. F., Wu M. X. and Schlossman S. F. (1999) Functional interaction of DFF35 and DFF45 with caspase-activated DNA fragmentation nuclease DFF40. J. Biol. Chem. 274, 2075920762.
  • Hannun Y. A. (1997) Apoptosis and the dilemma of cancer chemotherapy. Blood 89, 18451853.
  • Herr I., Wilhelm D., Bohler T., Angel P. and Debatin K. M. (1997) Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis. EMBO J. 16, 62006208.
  • Hilgard P., Klenner T., Stekar J. and Unger C. (1993) Alkylphosphocholines: a new class of membrane-active anticancer agents. Cancer Chemother. Pharmacol. 32, 9095.
  • Hirsch T., Marchetti P., Susin S. A., Dallaporta B., Zamzami N., Marzo I., Geuskens M. and Kroemer G. (1997) The apoptosis-necrosis paradox. Apoptogenic proteases activated after mitochondrial permeability transition determine the mode of cell death. Oncogene 15, 15731581.
  • Hosli P., Sappino A. P., De Tribolet N. and Dietrich P. Y. (1998) Malignant glioma: should chemotherapy be overthrown by experimental treatments? Ann. Oncol. 9, 589600.
  • Jarvis W. D., Kolesnick R. N., Fornari F. A., Traylor R. S., Gewirtz D. A. and Grant S. (1994) Induction of apoptotic DNA damage and cell death by activation of the sphingomyelin pathway. Proc. Natl. Acad. Sci. USA 91, 7377.
  • Jendrossek V., Erdlenbruch B., Hunold A., Kugler W., Eibl H. and Lakomek M. (1999) Erucylphosphocholine, a novel antineoplastic ether lipid, blocks growth and induces apoptosis in brain tumor cell lines in vitro. Int. J. Oncol. 14, 1522.
  • Jendrossek V., Kugler W., Erdlenbruch B., Eibl H., Lang F. and Lakomek M. (2001) Erucylphosphocholine-induced apoptosis in chemoresistant glioblastoma cell lines: involvement of caspase activation and mitochondrial alterations. Anticancer Res. 21, 33893396.
  • Kamesaki H. (1998) Mechanisms involved in chemotherapy-induced apoptosis and their implications in cancer chemotherapy. Int. J. Hematol. 68, 2943.
  • Kaufmann S. H. and Earnshaw W. C. (2000) Induction of apoptosis by cancer chemotherapy. Exp. Cell Res. 256, 4249.DOI: 10.1006/excr.2000.4838
  • Konstantinov S. M., Topashka-Ancheva M., Benner A. and Berger M. R. (1998) Alkylphosphocholines: effects on human leukemic cell lines and normal bone marrow cells. Int. J. Cancer 77, 778786.DOI: 10.1002/(SICI)1097-0215(19980831)77:5<778::AID-IJC18>3.0.CO;2-Y
  • Konstantinov S. M. and Berger M. R. (1999) Human urinary bladder carcinoma cell lines respond to treatment with alkylphosphocholines. Cancer Lett. 144, 153160.
  • Kötting J., Berger M. R., Unger C. and Eibl H. (1992) Alkylphosphocholines: influence of structural variation on biodistribution at antineoplastically active concentrations. Cancer Chemother. Pharmacol. 30, 105112.
  • Kroemer G. and Reed J. C. (2000) Mitochondrial control of cell death. Nat. Med. 6, 513519.DOI: 10.1038/74994
  • Li H., Zhu H., Xu C. J. and Yuan J. (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94, 491501.
  • Locksley R. M., Lilleen N. and Lenardo M. J. (2001) The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104, 487501.
  • Luo X., Budihardjo I., Zou H., Slaughter C. and Wang X. (1998) Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 94, 481490.
  • McCarthy N. J., Whyte M. K., Gilbert C. S. and Evan G. I. (1997) Inhibition of Ced-3/ICE-related proteases does not prevent cell death induced by oncogenes, DNA damage, or the Bcl-2 homologue Bak. J. Cell Biol. 136, 215227.
  • Marsters S. A., Pitti R. M., Donahue C. J., Ruppert S., Bauer K. D. and Ashkenazi A. (1996) Activation of apoptosis by Apo-2 ligand is independent of FADD but blocked by CrmA. Curr. Biol. 6, 750752.
  • Medema J. P., Scaffidi C., Kischkel F. C., Shevchenko A., Mann M., Krammer P. H. and Peter M. E. (1997) FLICE is activated by association with the CD95 death-inducing signaling complex (DISC). EMBO J. 16, 27942804.
  • Miller T. M., Moulder K. L., Knudson C. M., Creedon D. J., Deshmukh M., Korsmeyer S. J. and Johnson E. M. Jr (1997) Bax deletion further orders the cell death pathway in cerebellar granule cells and suggests a caspase-independent pathway to cell death. J. Cell Biol. 139, 205217.
  • Noseda A., White J. G., Godwin P. L., Jerome W. G. and Modest E. J. (1989) Membrane damage in leukemic cells induced by ether and ester lipids: an electron microscopic study. Exp. Mol. Pathol. 50, 6983.
  • Pushkareva M. Y., Wannberg S. L., Janoff A. S. and Mayhew E. (2000) Increased cell-surface receptor expression on U-937 cells induced by 1-O-octadecyl-2-O-methyl-sn-glycero-3-phosphocholine. Cancer Immunol. Immunother. 48, 569578.
  • Raff T., Van Der Giet M., Endemann D., Wiederholt T. and Paul M. (1997) Design and testing of β-actin primers for RT–PCR that do not co-amplify processed pseudogenes. Biotechniques 23, 456460.
  • Reed J. C. (2000) Mechanisms of apoptosis. Am. J. Pathol. 157, 14151430.
  • Schaller M. D. (2001) Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim. Biophys. Acta 1540, 121.
  • Slee E. A., Harte M. T., Kluck R. M., Wolf B. B., Casiano C. A., Newmeyer D. D., Wang H. G., Reed J. C., Nicholson D. W., Alnemri E. S., Green D. R. and Martin S. J. (1999) Ordering the cytochrome c-initiated caspase cascade: hierarchical activation of caspases-2, -3, -6, -7, -8, and -10 in a caspase-9-dependent manner. J. Cell Biol. 144, 281292.
  • Slee E. A., Keogh S. A. and Martin S. J. (2000) Cleavage of BID during cytotoxic drug and UV radiation-induced apoptosis occurs downstream of the point of Bcl-2 action and is catalysed by caspase-3: a potential feedback loop for amplification of apoptosis-associated mitochondrial cytochrome c release. Cell Death Differ. 7, 556565.
  • Suliman A., Lam A., Datta R. and Srivastava R. K. (2001) Intracellular mechanisms of TRAIL: apoptosis through mitochondrial-dependent and -independent pathways. Oncogene 20, 21222133.
  • Wajant H., Johannes F. J., Haas E., Siemienski K., Schwenzer R., Schubert G., Weiss T., Grell M. and Scheurich P. (1998) Dominant-negative FADD inhibits TNFR60-, Fas/Apo1- and TRAIL-R/Apo2-mediated cell death but not gene induction. Curr. Biol. 8, 113116.
  • Wesselborg S., Engels I. H., Rossmann E., Los M. and Schulze-Osthoff K. (1999) Anticancer drugs induce caspase-8/FLICE activation and apoptosis in the absence of CD95 receptor/ligand interaction. Blood 93, 30533063.
  • Xiang J., Chao D. T. and Korsmeyer S. J. (1996) BAX-induced cell death may not require interleukin 1β-converting enzyme-like proteases. Proc. Natl. Acad. Sci. USA 93, 1455914563.
  • Yamaguchi S., Kitagawa M., Inoue M., Tomizawa N., Kamiyama R. and Hirokawa K. (2000) Cell dynamics and expression of tumor necrosis factor (TNF)-α, interleukin-6, and TNF receptors in angioimmunoblastic lymphadenopathy-type T cell lymphoma. Exp. Mol. Pathol. 68, 8594.DOI: 10.1006/exmp.1999.2297
  • Yeh W. C., Pompa J. L., McCurrach M. E., Shu H. B., Elia A. J., Shahinian A., Ng M., Wakeham A., Khoo W., Mitchell K., El-Deiry W. S., Lowe S. W., Goeddel D. V. and Mak T. W. (1998)FADD: essential for embryo development and signaling from some, but not all, inducers of apoptosis. Science 279, 19541958.
  • Zhang J. H. and Xu M. (2000) DNA fragmentation in apoptosis. Cell Res. 10, 205211.